Combined PARP and PD-L1 inhibition: a promising treatment option for relapsed small-cell lung cancer

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC11228726 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature